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Abstract
Background: Myostatin, a muscle-specific member of the Transforming Growth Factor beta
family, negatively regulates muscle development. Double-muscled (DM) cattle have a loss-of-
function mutation in their myostatin gene responsible for the hypermuscular phenotype. Thus,
these animals are a good model for understanding the mechanisms underpinning muscular
hypertrophy. In order to identify individual genes or networks that may be myostatin targets, we
looked for genes that were differentially expressed between DM and normal (NM) animals (n = 3
per group) in the semitendinosus  muscle (hypertrophied in DM animals) at 260 days of fetal
development (when the biochemical differentiation of muscle is intensive). A heterologous
microarray (human and murine oligonucleotide sequences) of around 6,000 genes expressed in
muscle was used.
Results: Many genes were found to be differentially expressed according to genetic type (some
with a more than 5-fold change), and according to the presence of one or two functional myostatin
allele(s). They belonged to various functional categories. The genes down-regulated in DM fetuses
were mainly those encoding extracellular matrix proteins, slow contractile proteins and ribosomal
proteins. The genes up-regulated in DM fetuses were mainly involved in the regulation of
transcription, cell cycle/apoptosis, translation or DNA metabolism. These data highlight features
indicating that DM muscle is shifted towards a more glycolytic metabolism, and has an altered
extracellular matrix composition (e.g. down-regulation of COL1A1 and COL1A2, and up-regulation
of COL4A2) and decreased adipocyte differentiation (down-regulation of C1QTNF3). The altered
gene expression in the three major muscle compartments (fibers, connective tissue and
intramuscular adipose tissue) is consistent with the well-known characteristics of DM cattle. In
addition, novel potential targets of the myostatin gene were identified (MB, PLN, troponins,
ZFHX1B).
Conclusion:  Thus, the myostatin loss-of-function mutation affected several physiological
processes involved in the development and determination of the functional characteristics of
muscle tissue.
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Background
Studies during the past decade have shown that the prod-
uct of the gene myostatin (GDF8) (a muscle-specific TGFβ
family member) is an inhibitor of muscle development
and of the maintenance of muscle mass. Mutations in
myostatin [1,2] result in double-muscling (DM) in both
cattle and rodents. In cattle, several disruptive myostatin
mutations have been identified in different breeds [3,4].
These mutations truncate the protein product resulting in
functional inactivation. For example, in the Belgian Blue
breed, an 11-bp deletion [nt821 (del11)] has occurred in
the third exon in a region encoding the bioactive domain.
Similarly, the Q204X mutation (a C to T transition),
which results in a premature stop codon in the N-terminal
LAP (Latency Associated Peptide) domain, is frequently
found in the Charolais breed or in the INRA95 genotype
[4].
Myostatin-null mice exhibit enlarged skeletal muscles rela-
tive to wild-type littermates because the numbers (hyper-
plasia) and area (hypertrophy) of muscle fibers are
increased [1]. In cattle breeds, double-muscling is prima-
rily due to hyperplasia [5] as early as the fetal period [6,7].
Myostatin  expression is regulated throughout gestation
[2,8]. It was found to be located in the most recently dif-
ferentiating cells throughout bovine fetal development
[9]. Myostatin may negatively regulate the number of fast-
glycolytic (IIX) fibers, which is therefore increased in DM
muscles at the expense of oxidative fibers [8]. Further-
more, the properties of DM muscles differ from those of
normal ones (NM) owing to lower collagen and intramus-
cular fat contents [10]. In adult muscle, myostatin is specif-
ically expressed in satellite cells and behaves as an
important regulator of satellite cell activation and
renewal, thereby controlling muscle mass (reviewed in
[11,12]).
Examination of the molecular action of myostatin has
revealed that it inhibits the proliferation of myogenic cells
through the control of cell cycle progression [13]. This
provides an explanation for the higher proliferation rates
of DM fetal myoblasts than controls in vitro [8,14].
Myostatin also protects myoblasts from apoptosis and
delays their terminal differentiation [15,16]. Functional
myostatin binds to the activin type IIB transmembrane
receptor, which then recruits and activates the ALK type I
co-receptor by phosphorylation. This results in recruit-
ment of the SMAD signaling pathway [17]. An alternative
pathway involving p38 MAPK signaling has also been pro-
posed to account for growth inhibition [18]. The inhibi-
tion of myogenesis is mediated partially through a
decreased expression of Myogenic Regulatory Factors
(reviewed in [12]). Myogenin and p21CKI have been
identified as the major physiological targets of endog-
enous myostatin in murine cells [19]. Proteomics has also
revealed novel differentially-expressed proteins associated
with double-muscling in bull calves [20], suggesting the
existence of unidentified myostatin targets.
In order to identify differences in gene expression, and
hence novel genes or networks that may be myostatin tar-
gets liable to be involved in muscle differentiation, we
examined the transcriptional profiling of the semitendino-
sus (ST) muscle of DM fetuses vs Non-Double-Muscled
(NM) at 260 days of gestation.
Results and Discussion
Microarray experiments
We performed microarray analyses of the ST muscle of
DM of the INRA95 genotype and NM fetuses (n = 3 per
group) using heterologous oligonucleotide chips (Myo-
chips, human and murine sequences) dedicated to muscle
and cardiac gene expression. The ST muscle was chosen
since it is highly hypertrophied in DM. The rationale for
studying gene expression in late fetuses was that expres-
sion of many genes is affected during the last third of ges-
tation [21], a key period in the fiber differentiation/
specialization process in cattle, which are mature at birth
with regard to muscle physiology [22]. The arrays have the
advantage of high quality and specificity together with a
large number of genes. Some 75% of their oligonucleotide
sequences are human, which was another advantage for
the study since the comparative coverage of the bovine
and human genomes is about 91% [23]. Myostatin
expression in ST muscle was monitored by quantitative
RT-PCR (Figure 1) and was found to be lower in DM than
NM muscle. However, it was more elevated in one of the
DM foetuses, which was found to be heterozygous for the
Q204X mutation.
Hybridization of bovine targets on to the Myochips ena-
bled us to recover 75–84% of valid expression values.
Myostatin expression in the ST muscle of experimental  fetuses Figure 1
Myostatin expression in the ST muscle of experimental 
fetuses. Myostatin expression was assessed by quantitative 
RT-PCR using the Sybergreen method. Values are means ± 
S.E. for n = 6. The highest crossing point (Ct) corresponds to 
the lowest expression level. DM: double-muscled fetus; NM: 
non-double-muscled fetus. DM108 is heterozygous for the 
Q204X mutation.
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Examination of microarray data from DM and NM fetuses
allowed us to identify major differences in gene expres-
sion amongst individuals and genotypes.
Hierarchical clustering of the data allowed the genotype
groups to be clearly discriminated (DM/NM, Figure 2).
However, it revealed a transcriptional profile for the het-
erozygote DM108 fetus more closely related to that of the
NM animals (Figure 2A, B). Principal component analysis
confirmed this finding (Figure 2C). Thus, muscle gene
expression appeared to be altered in fetuses harbouring
the Q204X mutation. However, this influence differed
according to whether one or two impaired myostatin
allele(s) were present, illustrating the autosomal recessive
character of myostatin in cattle [24], as already shown for
muscle protein expression [20].
Expression data were filtered for 20% missing values and
processed by ANOVA. Eight clusters were selected. They
included 189 genes the expression of which varied accord-
ing to the presence of one or two functional myostatin
allele(s) as shown by the hierarchical clustering. Only 142
of them had a GO annotation. Some of these could be
potential candidate targets of functional myostatin.
Twelve were also found to be differentially expressed post-
natally in the ST muscle of DM vs NM cows (our unpub-
lished data). Using FatiGO+, an evolution of FatiGO, we
searched for GO functional annotation and the KEGG
pathway. Some genes were annotated for carbohydrate
metabolism (e.g. Foxc2, SDS, APM1), for lipid, fatty acid
and steroid metabolism (e.g. PLIN, APM1), or for protein
metabolism and modification (e.g. Mrpl36, CTBP1, PAK1,
SMAP1). Interestingly, these putative myostatin targets
were predicted to belong to 51 different KEGG pathways
(Table 1) such as focal adhesion, axon guidance, calcium
signaling pathway, cell cycle, or lastly Wnt signaling,
which was recently shown to be altered in myostatin
knocknull-out mice [25].
Differentially expressed genes according to myostatin loss-
of-function
Using SAM, a differential analysis of the hybridization
data was carried out between the two groups of three
fetuses (dataset 1, Table 2). It was also performed between
two groups of two extreme fetuses (dataset 2 excluding the
DM108 heterozygote and an NM0423 animal, the
myostatin expression and gene profiling of which were
intermediate) to maximize the difference between the two
genotypes (Table 2). The latter analysis was chosen in
order to identify true differentially expressed genes with
confidence. Analyses allowed a false discovery rate (FDR)
that accepts that 5‰ of the genes declared differentially
expressed will be false positives. In both analyses, a sub-
stantial number of genes were differentially expressed and
this number varied according to the fold change value
(FC). More than 93% of the genes identified from dataset
1 were declared to be differentially expressed from dataset
2 (Table 2). Taking a FC ≥ 2, the same genes were identi-
fied in both datasets. However, dataset 2 allowed an addi-
tional 53 down- and 86 up-regulated genes to be
identified with a FC ≥ 1.4 (Table 2). The rationale for tak-
ing differential expression with a FC ≥ 1.4 and FDR < 5‰
into account was to ensure that greater numbers of differ-
ential genes were retained with high confidence, using 4
technical replications per animal.
Examples of genes declared differential by SAM from data-
set 2 are presented in Table 3 (up-regulated genes) and
Table 4 (down-regulated genes). ANOVA confirmed that
the expression of 93% of these genes was statistically sig-
nificant (F>11, p < 0.005). The genes with FC ≥ 2 had p-
values < 5‰ by ANOVA, except one (2410044K02Rik, p-
value  < 0.02). Some differential expressions were con-
firmed by real-time RT-PCR (Table 5). A search for homol-
ogy between the oligonucleotides representing
differential genes with a FC = 1.4 and the bovine genome
was carried out using BLASTN and BLASTX searches. More
than 80% of the oligonucleotides were found to have a
homology greater than 70% with bovine sequences (data
presented partially in Tables 3 and 4). These data con-
firmed the appropriateness of the oligochips even though
they were made of human and murine oligonucleotide
sequences.
Function of differential genes in DM and biological 
relevance
The data were further explored using Gene Ontology
(GO) information (Biological Process and Molecular
Function terms). This predicted that 95 of the down-regu-
lated genes with GO annotations encoded mainly ribos-
omal proteins, ECM/cell interaction proteins or
sarcomeric slow contractile proteins. Conversely, the
genes up-regulated in DM muscle were annoted for regu-
lation of the cell cycle, transcription and DNA metabo-
lism. Only 136 of the 242 up-regulated genes had a GO
annotation at the Biological Process level. Of these, 30
were annotated for "regulation of transcription", of which
24 were annotated with the GO term "Transcription Fac-
tor". They included regulators of muscle-specific gene
expression such as MEF2A, ID1 or ZFX1B (ZEB2/SIP1)
and also MyoD1 for which the FC (1.35) was just under
our FC threshold (1.4).
Some down-regulated genes were found to belong to
KEGG pathways (Table 6), e.g. the ribosome, oxidative
phosphorylation and ATP synthesis, calcium signaling
pathway and extracellular matrix (ECM)/receptor interac-
tion. Up-regulated genes were mainly involved in the
insulin pathway, cytokine/receptor interaction, Wnt sign-
aling, cell cycle, apoptosis and axon guidance (Table 6).BMC Genomics 2007, 8:63 http://www.biomedcentral.com/1471-2164/8/63
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Hierarchical clustering and Principal Components Analysis of expression data reveal the influence of heterozygosity for the  Q204X mutation and the variability of gene expression among individuals Figure 2
Hierarchical clustering and Principal Components Analysis of expression data reveal the influence of heterozygosity for the 
Q204X mutation and the variability of gene expression among individuals. Four individual arrays were used per animal. Cluster-
ing (A, B) and PCA (C) were performed using Genesis and GenANOVA respectively. (A): Hierarchical clustering of genes – 
each column represents an individual array; (B): Hierarchical clustering of animals' mean (-M) expression data; (C): PCA of ani-
mals, each projection is representative of an individual array; DM: double-muscled fetus; NM: non-double-muscled fetus. 
DM108 is  heterozygous for the Q204X mutation.BMC Genomics 2007, 8:63 http://www.biomedcentral.com/1471-2164/8/63
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Altogether, these results indicated that myostatin loss-of-
function was associated with the alteration of many bio-
logical pathways in DM muscle.
Genes involved in protein metabolism
One notable finding of our study was that an important
subset of the differential genes was involved in protein
metabolism or encoded ribosomal proteins. Interestingly,
some authors have specifically looked for genes that are
differentially regulated in early DM embryos compared to
normal ones [26]. As in the present study, they identified
differential expression of ribosomal proteins, suggesting
that NM and DM animals may differ in protein degrada-
tion and synthesis.
Genes involved in contractile and metabolic function
The functional categories of the genes down-regulated in
DM illustrate the so-called phenotypic muscle characteris-
tics of these animals. First, the findings highlighted a
marked down-regulation of genes encoding slow contrac-
tile proteins in fibers (e.g. cardiac and slow troponin C and
T isoforms, MYH7 and MYL2, TPM3; Table 4), slow twitch
proteins (e.g. PLN, and SERCA2; Table 4) and MB
(myoglobin), the differential expression of some of these
genes being confirmed by real-time RT-PCR (Table 5). The
Bibliosphere Pathway Edition web tool of the Genomatix
Suite predicted that, in rodents or humans, some of the
down-regulated genes (SERCA2, MyH7, S100A4, VIM,
FN1, COL1A2) had an NFKB1 site in their promoter.
Interestingly, the NFKB1 gene was found to be up-regu-
lated in DM (FC = 1.33, FDR < 5‰, p value < 5‰), sug-
gesting that NFKB1 expression could contribute to
negative regulation of their expression as already shown
for collagen COL1A2 [27]. Other genes involved in con-
traction (MYH7, MB, TNN C, desmin) were also predicted
to be targets of TEF-1 at MEF2 elements during fast-to-
slow muscle conversion, as reported for humans [28].
Conversely, the study also showed up-regulation of
slc16a10 (Table 3), which encodes a transporter catalyzing
the transport of many monocarboxylates including lactate
and pyruvate [29], and of LDH-A, which encodes lactate
dehydrogenase, although with an FC below our threshold
(1.37). Moreover, it confirmed that the expression of
MyBP-H, which encodes a component of the thick fila-
ments in fast skeletal muscles, was up-regulated (Table 3)
in the ST muscle of DM fetuses, as shown postnatally by
proteomic approaches [20]. All in all, these data indicated
that DM muscles were shifted towards a more glycolytic
Table 2: Numbers of genes declared by SAM to be differentially 
expressed (FC ≥ 1.4, FDR < 5‰) in the Semitendinosus muscle of 
DM vs NM fetuses.
Down-regulated 
genes
Up-regulated 
genes
Data set 1 (total) 134 156
Data set 2 (reduced) 178 242
Genes in common 125 156
Dataset 1 comprised expression data from 3 fetuses per group; 
dataset 2 excluded the data from the DM108 heterozygote fetus and 
from the NM0423 fetus.
Table 1: KEGG pathway results of the genes of which the expression varied according to whether one or two functional myostatin 
allele(s) were present.
KEGG Entity Genes list Percentage of annoted genes list
Focal adhesion FN1, ITGA4, ITGA3, ARHA, COL1A1, CAPN3, CAV3, RRAS2 5.6
Axon guidance ABLIM1, SEMA3D, ARHA, RRAS2, Limk1, NFAT5 4.2
Regulation of actin cytoskeleton FN1, ITGA4, ITGA3, ARHA, RRAS, Limk1 4.2
Neuroactive ligand-receptor interaction ADRA1B, GPR50, EDN2, EDNRA, THRA, GPR72 4.2
Calcium signaling pathway ADRA1B, CAMK4, EDNRA, NFAT5, PRKACG 3.5
Cell cycle Mcm6, HDAC4, SMC1L2, E2F1 2.8
Wnt signaling pathway ARHA, CTBP1, NFAT5, PRKACG 2.8
Insulin signaling pathway TSC, RRAS2, FASN, PRKACG 2.8
Glutathione metabolism G6PD, Gclc, Gpx3, MGST1 2.8
ECM-receptor interaction FN1, ITGA4, ITGA3, COL1A1 2.8
Cell adhesion molecules (CAMs) ITGA4, NECL1, NCAM1 2.1
Ribosome Rps29, RPL37A, RPL28 2.1
MAPK signaling pathway DUSP9, RRAS2, PRKACG 2.1
T cell receptor signaling pathway ARHA, RRAS2, NFAT5 2.1
Expression data were filtered for 20% missing values, processed by ANOVA and by Genesis. A total of 189 genes were selected from 8 clusters for 
similar regrouping according to the homozygote or heterozygote status of the Q204X mutation. They were submitted to FatiGo+ search. Out of 
the 189 genes examined, 142 had a GO annotation, 42 were unknown and 5 had.... more than one ensemble ID. Amongst the 51 KEGG pathways 
found, only the KEGG pathway results including several genes are presented.BMC Genomics 2007, 8:63 http://www.biomedcentral.com/1471-2164/8/63
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fast metabolism. A similar observation was reported in
myostatin-null mice [25,30]. Moreover, it has been dem-
onstrated that the muscles of DM cattle contain a higher
proportion of fast glycolytic IIX fibers and a lower propor-
tion of slow I fibers than NM muscles as early as late ges-
tation [31]. Proteomics showed increased expression of
fast proteins and lowered expression of slow proteins in
the ST muscle of DM bull calves [20]. Accordingly, our
study revealed gene expression profiles that may be
molecular signatures of the DM fast-type phenotype. Such
features are likely to originate from a high proportion in
the secondary generation of muscle fibers following the
loss of myostatin function, as early as Day 110 of fetal age
in cattle [8].
ECM-specific genes
It is notable that genes encoding ECM/cell interaction
proteins, e.g. COL1A1,  COL1A2  and  COL3A1  (collagen
type I and III), FN1 (murine and human fibronectin 1),
LAMB1 (laminin beta 1), and BGN  (biglycan, a known
TGFβ target gene [32]) are down-regulated in DM mus-
cles. ECM has a profound influence on the differentiation
of muscle cells and can regulate growth factor function in
skeletal muscle (for a review, see [33]). Our data are in
accordance with the reduced connective tissue content in
DM muscles [34,35] and the decreased expression in DM
fetal muscles of the major collagen isoforms, namely the
type I and III collagens, as shown by in situ experiments
[36]. Conversely, a novel result of the present study was
the up-regulation of genes encoding type IV collagen, the
major structural component of basement membrane sur-
rounding and supporting skeletal muscle cells, and
PLOD3, an enzyme playing an essential role in the
supramolecular assembly of collagen IV [37]. Collagen IV
was shown to be located mainly in the endomysium
whereas collagen I and III isoforms are located both in the
perimysium and endomysium [36]. Thus, the ultrastruc-
ture of the DM muscle connective tissue could differ from
that of NM at both the endomysium and the perimysium
levels.
Gene marker of adipocyte differentiation
Lastly, the most novel and interesting result of our study
is the down-regulated expression of C1QTNF3 (Table 4),
the differential expression of which was confirmed by RT-
PCR (Table 5). This gene encodes an adipocyte differenti-
ation marker with striking homologies with adiponectin
[38]. Similarly, decreased C1QTNF3  expression was
detected in DM cows (our unpublished data). The finding
that a loss-of-function mutation of myostatin is associated
with decreased adipocyte differentiation is consistent with
the low fat depots in myostatin-null mice [39] and in DM
cattle [35]. Recently, myostatin has been shown to pro-
mote the commitment of mesenchymal stem cells to the
adipogenic lineage [40]. Potts et al. [26] have also
reported decreased expression of HMGA2, a transcription
factor involved in fat cell proliferation, in DM cattle
embryos. The expression of another adipocyte differentia-
Table 3: Examples of up-regulated genes in DM semitendinosus.
Gene symbol Gene name Fold change Homology
2610103N14Rik Slc16a10 Solute carrier family 16 2.76 53%
2410044K02Rik Thoc3 THO complex 3 2.64 96%
SURF1 Surfeit 1 2.54 88%
LOC58504 Hypothetical protein from clones 23549 and 23762 2.52 86%
Slc26a4 Solute carrier family 26, member 4 2.48 ND
FLJ13855 Hypothetical protein FLJ13855 2.36 94%
C8orf1 Chromosome 8 open reading frame 1 2.27 92%
MYBPH Myosin binding protein H 2.27 90%
CXORF6 Chromosome × open reading frame 6 2.19 50%
ACCN2 Amiloride-sensitive cation channel 2, neuronal 2.17 ND
MYOM2 Myomesin (M-protein) 2, 165kDa 2.14 84%
Olfr51 Olfactory receptor 51 2.13 51%
Fancg Fanconi anemia, complementation group G 2.12 80%
4631402N15Rik Usp38 Ubiquitin specific protease 38 2.10 56%
Rusc2 RUN and SH3 domain containing 2 2.05 80%
C:3410 EST 2.02 ND
PDF Peptide deformylase-like protein 2.01 86%
COL4A2 Collagen type, IV, alpha2 1.84 86%
PLOD3 Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 1.80 92%
FURIN Furin 1.63 86%
ZFHX1B Zinc finger homeobox 1b 1.58 100%
Genes were declared differentially expressed by SAM (FDR < 5‰) and by GeneANOVA with a p-value < 2% from dataset 2. Percentage 
homologies between spotted oligonucleotides and bovine sequences were determined using BLASTN and BLASTX searches. ND: None 
determined (unknown bovine sequence).BMC Genomics 2007, 8:63 http://www.biomedcentral.com/1471-2164/8/63
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Table 5: Validation of differential expression by real time PCR.
Gene Ratio NM/DM by array analysis Ratio NM/DM by RT-PCR
TPM3 3.38* 4.45*
ATP2A2 2* 2.85*
MYH7 4.86-*3.37* 3.28*
C1QTNF3 1.87* 2.97*
PLN 5.48* 4.31*
COL1A 5.22*-2.98* 10
BGN 1.79* 5.05*
PLOD3 1.80* 1.4*
Results are means of duplicate experiments. *All differential expressions are statistically significant at P < 5% for array experiments (using SAM 
analysis; comparison of 2 NM vs 2DM animals) or by real-time RT-PCR (using the Mann Whitney U Test).
Table 4: Examples of down-regulated genes in DM semitendinosus.
Gene Gene name Fold change Homology
Tncc Troponin C, cardiac/slow skeletal 6.22 94%
PLN Phospholamban 5.48 98%
ALPHA-1COLLAGEN-a Alpha-1 collagen type 1 5.22 98%
MYH7-a Myosin, heavy polypeptide 7, 
cardiac muscle, beta
4.86 96%
TNNC1 Troponin C, slow 4.71 94%
Tpm3 Tropomyosin 3 3.38 94%
MYH7-b Myosin, heavy polypeptide 7, 
cardiac muscle, beta
3.37 90%
TNNC1 Troponin C, slow 3.32 92%
COL3A1 Collagen, type III, alpha 1 2.98 96%
ALPHA-1COLLAGEN-b Alpha-1 collagen type 1 2.97 98%
VIM Vimentin 2.76 94%
COL1A2 Collagen, type I, alpha 2 2.64 84%
GPR72 G protein-coupled receptor 83 2.52 ND
S100A4 S100 calcium binding protein A4 2.38 92%
COL1A1 Collagen, type I, alpha 1 2.26 80%
GL004 Chromosome 2 open reading 
frame 33
2.25 94%
Fn1 Fibronectin 1 2.11 90%
MYL2 Myosin, light polypeptide 2, 
regulatory, cardiac, slow
2.08 92%
MRPL15 Mitochondrial ribosomal protein 
L15
2.01 84%
hypothLOC150928 Hypothetical LOC150928 2.01 98%
SERCA2 ATPase, CA++ transporting, 
cardiac muscle
2.00 94%
MB Myoglobin 1.90 90%
Genes were declared differentially expressed by SAM (FDR < 5‰) and by GeneANOVA with a p-value < 1‰ from dataset 2. Percentage 
homologies between spotted oligonucleotides and bovine sequences were determined using BLASTN and BLASTX searches. ND: none determined 
(unknown bovine sequence). -a, -b indicate two different oligonucleotides designed for a same gene.BMC Genomics 2007, 8:63 http://www.biomedcentral.com/1471-2164/8/63
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tion marker (A-FABP) was found to be lower in the mus-
cles of DM Belgian Blue bulls compared to bulls with no
myostatin mutation [41], illustrating a reduction in intra-
muscular adipocyte numbers. Since the number of intra-
muscular adipocytes is a major factor in determining
muscle marbling of beef [42], it could partly explain the
lower intramuscular fat development of DM muscles [35].
Conclusion
In conclusion, transcriptomic analysis enabled us to dem-
onstrate that the biological traits of DM muscles are asso-
ciated with specific gene profiles at the time of fiber
differentiation and/or specialization in late fetuses. On
the one hand, our results confirm previous data obtained
postnatally by classical biochemical and molecular bio-
logical approaches. On the other hand, they reveal altered
gene expression in the three major muscle compartments,
namely fibers, connective tissue and intramuscular adi-
pose tissue. This may help us to understand how myostatin
loss-of-function affects so many qualitative properties of
muscles. Lastly, this study revealed novel putative myosta-
tin targets, e.g. ECM constituents such as type IV collagen,
C1QTNF3 mainly associated with adipose tissue develop-
ment, and genes encoding transcription factors (ZFH1XB,
...). Work is in progress to determine whether these genes
are direct or indirect targets targets of myostatin throught
the examination of putative gene networks.
Methods
Animals
Animals were obtained as described previously [43]. Only
260-day-old fetuses were used in this study. Three DM
fetuses were obtained by artificial insemination of Cha-
rolais heifers by transplantation of frozen embryos of
strain INRA95. This strain comprised a mixture of breeds
and the transplanted embryos contained around 75%
Charolais. Three normal Charolais fetuses were obtained
by artificial insemination of Charolais heifers using Cha-
rolais sperm from non-DM sires. After slaughter, the
fetuses were collected and the semitendinosus muscle was
excised, snap frozen and stored at -80°C prior to analysis.
Microarray experiments
Transcriptomic analysis was performed with a microarray
of around 6,000 genes expressed in muscle; these so called
"Myochips" are available from West Genopole [44]. The
Myochips were made from a set of relevant genes
(probes). They were composed of 919 control spots and
6,473 oligonucleotides (50-mers) representing genes pref-
erentially and/or differentially expressed in normal and
diseased striated mice or human muscles and heart. These
genes encode proteins belonging to all the main func-
tional categories in striated muscle [44]. They were classi-
fied at the biological process level according to Gene
Ontology annotations. Three replicates of each gene were
spotted on to Myochips, which allowed detailed statistical
studies of the reproducibility of the hybridization experi-
ments. Microarray experiments were performed according
to recently proposed standards (MIAME consortium
[45]). Data were incorporated into the BASE database and
the NCBI Gene Expression Omnibus (GEO) [46] and are
accessible through GEO Series accession number
GSE5456.
The protocol used was that described in the DNA Chips
platform protocols. Total RNA was extracted from muscle
tissue samples with TRIZOL® reagent (Life Technologies)
according to the manufacturer's recommendation. Each
individual sample was compared to a reference pool con-
sisting of skeletal muscle transcripts isolated from the
semitendinosus muscles of five 260-day-old NM fetuses and
of 16 Charolais heifers. Total RNA (15 µg) was reverse
Table 6: Main KEGG pathways involving the genes of which expression was either down- or up-regulated in DM semitendinosus.
KEGG Entity Down-regulated genes list % of list Up-regulated genes list % of list
Ribosome RPS3A, RPS15A, Rpl30, RPS20, UBA52, 
RPL32, Rps24
14.29 No genes 0
Oxidative phosphorylation ATP5A1, ATP5E, COX5A, Cox5b, ATP5F1, 
ATP5G2, NDUFS1
14.29 No genes 0
Insulin signaling pathway No genes 0 MRAS, PRKAA1, TSC, RRAS2, 
PRKACG
10.2
ECM-receptor interaction Fn1, COL1A1, COL1A2, Sdc4, LAMB1, 
COL3A1
12.24 ITGA3 2.0
ATP synthesis ATP5A1, ATP5E, ATP5F1, ATP5G2 8.16 No genes 0
Cytokine-cytokine receptor interaction No genes 0 TNFRSF14, LTB, CCL18, IL21R 8.2
Wnt signaling pathway WNT6 2.04 Porcn, WNT8B, CTBP1, PRKACG 8.2
Axon guidance No genes 0 MRAS, RRAS2, Limk1 6.2
Calcium signaling pathway ATP2A2, PLN, Cacna1i, GNAS, Erbb4 10.2 CACNA1F, PRKACG 4.1
Genes were declared differentially expressed by SAM (FDR < 5‰) and by GeneANOVA with a p-value < 1‰ from the reduced dataset. The gene 
lists were submitted to FatiGO+ analysis and compared for KEGG pathway.BMC Genomics 2007, 8:63 http://www.biomedcentral.com/1471-2164/8/63
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transcribed using the CyScribe cDNA Post Labelling kit
(Amersham Pharmacia Biotech) using random nanomers
for priming. During reverse transcription, aminoallyl-
dUTP was incorporated to perform labeling with cyanins
(Cy5 for the reference sample and Cy3 for individual sam-
ples). Four chips were hybridized per sample comparison.
After washing, the chips were scanned on an Affymetrix
428™ Array Scanner.
Data analysis
After acquisition, the scanned images were analyzed using
GenePix Pro V6 software (Axon instrument, Inc). Raw sig-
nal intensity data were normalized using the MADSCAN
lowess fitness method [47]. In order to identify differen-
tially expressed genes, the Cy3/Cy5 ratios were statistically
analyzed using SAM [48]. Data were also analyzed by
standard analysis of variance (ANOVA) using Gene-
ANOVA software [49]. In order to identify similar expres-
sion patterns, gene expression data were analyzed with
Genesis [50] using hierarchical clustering (Average link-
age and Euclidian distance).
Putatively involved pathways were explored using the
FatiGoplus web tool [51], which is an extension of FatiGO
[52] to other types of relevant biological knowledge, and
using the Bibliosphere Pathway Edition web tool of the
Genomatix Suite [53].
Differential expression was checked by RT-PCR for some
genes, e.g. TPM3 (Fw primer: CTGGAGGAGGAGCTGAA-
GAA; Rv primer: CAGCTTGGCTACCGATCTCT), SERCA2
(Fw primer: TCTGCCTGTCGATGTCACTC; Rv primer:
GTTGCGGGCCACAAACTT),  MYH7  (Fw primer: CAC-
CAACCTGTCCAAGTTCC; Rv primer: ACTGGGAGCT-
TCAGTTGCAC), PLN (Fw primer:
ACTTGGCTGGCAGCTTTTTA; Rv primer: ACTGGGATT-
GCAGCAGAACT),  C1QTNF3  (Fw primer: CGCTCACT-
TCACCAATCAGA; Rv primer:
TGCATGGTTGCTGGATGTAT), MSTN (Fw primer: GTCT-
GCCCTTGTTAATTACCAG; Rv primer: CATCAGAG-
CAACTTGAGGTGG),  COL1A1  (Fw primer:
CACCTACCACTGCAAGAACAG, Rv primer: GAAT-
GCACTTTTGGTTTTTGGTG), BGN (Fw primer: CACCTT-
GGTGATGTTGTTGG; Rv primer:
TCTCGTCCGCTACTCCAAGT),  PLOD3  (Fw primer:
AACGGGGCTTTAGATGAGGT; Rv primer: CGTGGTA-
CACCTCGTTGTTG) using a LightCycler FastStart DNA
Master SYBR Green I kit (Roche Diagnostics GmBH, Man-
nheim, Germany) according to the following procedure:
Mg2+ added at a final concentration of 2 mM; pre-incuba-
tion step at 95°C for 10 min; amplification step (40
cycles) including denaturation at 95°C for 10 s, annealing
at 60°C for 7 s, extension at 72°C for 10 s; melting curve
including denaturation at 95°C for 0 s, annealing at 70°C
for 20 s, continuous melting at 98°C for 0 s (slope =
0.1°C/s); cooling step at 40°C for 30 s. For MSTN,
annealing was at 56°C. Results are expressed in pg/µmol
relative to a standard curve of purified cDNA for each
gene. Expression data from the 2 homozygote DM fetuses
only and the 3 NM fetuses were analyzed using the Mann
Whitney U Test and the difference was declared significant
for U= 0 (p = 5%). For MSTN, annealing was at 56°C.
Results are expressed as Ct values.
List of abbreviations used
SAM: Statistical Analysis of Micro-arrays; ECM: Extra Cel-
lular Matrix; DNA: Desoxyribo Nucleic Acid; NM: Nor-
mally-Muscled cattle; DM: Double-Muscled cattle, PCA:
Principal Components Analysis; FC: Fold Change; FDR:
False Discovery Rate.
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